Background: The incidence of food allergies has increased dramatically during the last decade. Recently, probiotics have been studied for the prevention and treatment of allergic disease. Objective: We examined whether Bifidobacterium longum KACC 91563 and Enterococcus faecalis KACC 91532 have the capacity to suppress food allergies. Methods: B longum KACC 91563 and E faecalis KACC 91532 were administered to BALB/c wild-type mice, in which food allergy was induced by using ovalbumin and alum. 
Food allergy is a potentially serious disease caused by abnormal immune responses to food or food additives. Recently, hospital visits for food allergy have dramatically increased. 1 Even though it has long been known that foods, such as peanuts, milk, shellfish, wheat, and tree nuts, trigger food allergies, causative factors have not been well defined. 2 Several treatments for food allergy have been proposed, including avoidance of allergenic foods, the most widely used method, 3 and, more recently, tolerance induction through oral allergen administration. [2] [3] [4] Alternatively, treatment with probiotics has been attempted in patients with food allergy. 5 Probiotics are live microorganisms that confer benefits to the host either directly through communication with host cells or indirectly through interaction with other gut bacteria. 6 Recent studies have suggested that probiotic bacteria affect the host immune system and suppress inflammatory and allergic responses. For example, Bifidobacterium breve enhances intestinal homeostasis through induction of IL-10-producing T R 1 cells. 7 Furthermore, a mixture of probiotics was shown to suppress experimental colitis by facilitating the generation of CD4 1 regulatory T (Treg) cells in the gut. 8 Double-stranded RNA from lactic acid bacteria triggers IFN-b production by dendritic cells (DCs), thereby inhibiting colitis. 9 In addition, VSL#3, a probiotic mixture consisting of 8 different gram-positive bacteria, suppresses food allergy through shifting immune responses from T H 2 to T H 1.
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Microbiota secrete extracellular vesicles (EVs), which contain DNA, protein, and cell-wall components within the nanometersized spherical lipid bilayer and recently have been spotlighted as key messengers. 11 Bacterial EVs deliver bacterial components to host immune cells in a concentrated, protected, and targeted form. 12 Both gram-positive and gram-negative bacteria secret EVs, [13] [14] [15] which influence the host immune system. 16 For example, DCs exposed to EVs of Bifidobacterium bifidum LMG13195 strongly promote differentiation of forkhead box protein 3 (Foxp3) 1 Treg cells. 17 Additionally, EVs of Staphylococcus aureus cause neutrophilic pulmonary inflammation through induction of T H 1 and T H 17 cell immune responses. 18 In a previous study, we isolated probiotics from fecal samples of healthy Korean neonates. Among them, we selected Enterococcus faecalis KACC 91532, a major strain, 19 and Bifidobacterium longum KACC 91563, a subspecies of B longum, which is a well-known probiotic strain exhibiting positive host effects. 20 The effects of these bacterial strains on food allergy have not been investigated previously. Here we show that oral administration of B longum KACC 91563 markedly decreases the severity of food allergy in a mouse model. In vitro, B longum KACC 91563-derived EVs containing family 5 extracellular solute-binding protein (ESBP) interact with mast cells and specifically induce cell death. ESBP is one of the extracellular solute-binding receptors of bacteria that function in chemoreception, transmembrane transport, and initiation of sensory transduction pathways and that recognize peptides. 21 However, any immunomodulatory function of ESBP has not been reported. In this study, we confirmed that ESBP decreases the severity of food allergy by reducing the number of mast cells in the small intestinal lamina propria (LP). Accordingly, we suggest a new mechanism of food allergy regulation by probiotics through the reduction of mast cells with no effect on T-cell responses.
METHODS Mice
Six-to 8-week-old BALB/c wild-type mice were provided by the Pohang University of Science and Technology mouse facility. All experiments were performed under specific pathogen-free conditions. We followed experimental protocols approved by the Animal Care and Use Committee of the Pohang University of Science and Technology.
Food allergy model
Food allergy was induced in mice, as described previously. 22 In brief, we intraperitoneally injected ovalbumin (OVA; 50 mg, grade V; Sigma-Aldrich, St Louis, Mo) with aluminum potassium sulfate adjuvant (1 mg; A-7210, Sigma-Aldrich) to mice once and then again 2 weeks later. Two weeks after the injections, OVA (10 or 50 mg) was administered orally every other day. Mice were deprived of food for approximately 3 to 4 hours before oral challenge with OVA. The degree of food allergy was evaluated based on diarrhea occurrence, which was assessed by visually monitoring mice for up to 1 hour after oral challenge. Multiple observers blinded to the experimental protocol scored the occurrence of diarrhea.
Administration of probiotics
B longum KACC 91563 and E faecalis KACC 91532 were provided by the National Institute of Animal Science, Rural Development Administration. They were isolated from feces of healthy Korean infants and anaerobically cultured at 378C. Although E faecalis KACC 91532 was cultured in MRS broth (BD Biosciences, San Jose, Calif), B longum KACC 91563 was cultured in MRS broth containing 0.05% cysteine. These cultured bacteria were freeze-dried with protectant based on skim milk and administered daily by means of intragastric gavage (5 3 10 9 colony-forming units [cfu] per mouse). In some experiments freeze-dried bacteria mixed with powdered mouse food were provided at the same cfu as bacteria in the oral gavage experiment, with fresh food administered every 3 days.
Fluorescence in situ hybridization
Bifidobacterium species and E faecalis in fecal samples were detected by using fluorescence in situ hybridization (FISH) kits (10MEH001 and 10MEH015; Ribo Technologies, Groningen, The Netherlands), according to the manufacturer's instructions.
Quantification of mast cells in the small intestine
After the fifth OVA intragastric challenge (50 mg) in a food allergy model, mice were sacrificed, and jejunal portions of the small intestines were prepared for paraffin sections. Jejunal tissue paraffin sections were stained with naphthol AS-D chloroacetate esterase (91C, Sigma-Aldrich), according to the manufacturer's instructions. Mast cells were counted in at least 3 different sections per mouse (magnification 3400).
Isolation of EVs
After culture of B longum KACC 91563 or E faecalis KACC 91532, culture medium was centrifuged at 8000 rpm for 20 minutes. As described previously, 23 the supernatant was filtered with a 0.22-mm bottle top filter and then centrifuged at 100,000g for 2 hours by using 0.8 and 2.5 mol/L sucrose solutions. After sucrose gradient centrifugation, the interlayer of the 0.8 and 2.5 mol/L sucrose was collected. The collected interlayer was diluted in PBS, and sucrose gradient centrifugation was performed one more time. Then the collected interlayer was centrifuged at 150,000g for 2 hours. Protein concentrations were measured with a BCA assay Kit (Thermo Scientific, Waltham, Mass). Size distribution of EVs was determined by using the dynamic light scattering assay, and imaging of EVs was conducted with transmission electron microscopy (TEM).
Cell preparation
LP cells of the small intestine were prepared, as described previously. 24 In brief, after fat tissues and Peyer patches were removed from the small intestine, the intestine was opened longitudinally, washed in PBS, and cut into approximately 1-to 2-cm lengths. For removal of epithelial cells, fragments of the small intestine were treated with PBS containing 10 mmol/L EDTA for 20 minutes at 378C with continuous stirring. After washing with PBS, the intestinal fragments were minced and digested with 400 U/mL collagenase D (Roche, Mannheim, Germany) and 100 mg/mL DNase I (Roche) at 378C for 45 minutes. LP cells were enriched through density gradient centrifugation in approximately 40% to 75% (vol/vol) Percoll (GE Healthcare Life Science, Fairfield, Conn). Then LP cells were stained with antibodies against CD11b, CD11c, CD19, MHC class II (MHCII), and T-cell receptor (TCR) b, and eosinophils (CD11b 
Apoptosis assay
T cells, B cells, and eosinophils isolated from the small intestine and bone marrow-derived mast cells (BMMCs) were incubated with whole bacteria B longum KACC 91563 or EVs (2 mg/mL) of B longum KACC 91563 or E faecalis KACC 91532 for 2 hours. Apoptotic cells were stained with Annexin V and 7-aminoactinomycin D.
In situ terminal deoxynucleotidyl transferasemediated nick end-labeling assay BMMCs were incubated either with whole bacteria or EVs (2 mg/mL) from E faecalis KACC 91532 or B longum KACC 91563 for 2 hours. Mast cells were washed, and cell slides were prepared with cytospin. Apoptotic cells were stained by using the DeadEnd Fluorometric in situ terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL) system (Promega, Madison, Wis), according to the manufacturer's instructions. Images of cells were obtained by means of Axio Scope.A1 fluorescent microscopy (Carl Zeiss, Oberkochen, Germany) after staining with 49-6-diamidino-2-phenylindole dihydrochloride.
Confocal microscopy
T cells, B cells, and eosinophils isolated from the small intestine, splenic DCs, and BMMCs were incubated with DiI (Invitrogen, Carlsbad, Calif)-labeled EVs (10 mg/mL) for 2 hours at 378C or 48C. After washing, cell slides were prepared by using the cytospin method for confocal microscopy. Images of cells were obtained at 3 400 magnification with the LSM 700 confocal microscope (Carl Zeiss) after staining with 49-6-diamidino-2-phenylindole dihydrochloride. Cells containing DiI-labeled EVs were counted in 25 different fields.
Proteomic analysis
EV proteins were separated by means of SDS-PAGE, and 2 major protein bands were excised. The gel pieces were treated with trypsin, according to a previously published in-gel digestion protocol. 25 Samples were then injected for liquid chromatography-tandem mass spectrometry. Mass data were acquired automatically by using Analyst QS 2.0 software (Applied Biosystems, Foster City, Calif). Database searches were performed by using Proteome Discoverer (version 1.3) against the nonredundant National Center for Biotechnology Information database (NCBInr; October 25, 2002) .
Protein purification
The ESBP and ABC transporter, substrate-binding protein (ASBP) genes of B longum KACC 91563 were inserted into the pGEX-4T-3 vector and expressed in Escherichia coli strain BL21. Glutathione-S-transferase (GST)-tagged ESBP and ASBP were induced by isopropyl b-D-1-thiogalactopyranoside and purified with glutathione Sepharose beads (GE Healthcare Life Science). 
Flow cytometry

ELISA
Mesenteric lymph node (MLN) cells were cultured for 72 hours at 378C in medium containing 100 mg/mL OVA. Concentrations of IL-4, IL-5, IL-10, IL-13, IL-17A, and IFN-g in culture supernatants were measured by using ELISA kits from eBioscience, according to the manufacturer's instructions. Concentrations of mast cell protease 1 (MCPT-1) and OVA-specific IgE in serum were measured by using ELISA kits (MCPT-1 ELISA kit [eBioscience] and OVA-specific IgE ELISA kit [Chondrex, Redmond, Wash]), according to the manufacturer's instructions.
Statistical analysis
All analyses were performed with GraphPad Prism 5 software (GraphPad Software, San Diego, Calif). For comparisons of the occurrence of diarrhea, Kaplan-Meier survival curve analysis was used, and P values were calculated by using the log-rank (Mantel-Cox) test. One-way ANOVA with the Newman-Keuls comparison posttest and Student t test were used to determine significant differences.
RESULTS
B longum KACC 91563 attenuates food allergy symptoms in a mouse model
In a previous study, B longum KACC 91563 and E faecalis KACC 91532 were isolated from fecal samples of healthy Korean neonates. 19, 26, 27 According to TEM analysis, B longum KACC 91563 and E faecalis KACC 91532 are rod-shaped and roundshaped bacteria, respectively (see Fig E1, A, in this article's Online Repository at www.jacionline.org). Because it was uncertain whether these 2 kinds of microbiota would reach the intestines of mice intact, we orally administered E faecalis KACC 91532 and B longum KACC 91563 for 2 weeks and observed bacteria in fecal samples using FISH. Both B longum KACC 91563 and E faecalis KACC 91532 were detected, and thus both B longum KACC 91563 and E faecalis KACC 91532 can reach the intestines of mice without being digested (see Fig E1, B) . To assess any effects of B longum KACC 91563 and E faecalis KACC 91532 on food allergy, we adopted an allergen-induced food allergy mouse model that induces dose-dependent acute diarrhea in BALB/c mice. 22 During food allergy induction, we orally treated mice with B longum KACC 91563 and E faecalis KACC 91532 daily (Fig 1, A) and found that B longum KACC 91563, but not E faecalis KACC 91532, suppressed the occurrence of diarrhea significantly (Fig  1, B) . Similarly, there was a delay in the onset of diarrhea in mice treated with B longum KACC 91563 when mice were challenged with low-dose OVA through the intragastric route (see Fig E2 in this article's Online Repository at www.jacionline. org). The number of bacteria seemed to be an important factor for this suppressive effect because diarrhea was not prevented at less than 5 3 10 9 cfu of bacteria per mouse per day (data not shown). In conclusion, our data indicate that B longum KACC 91563 has the ability to ameliorate symptoms of food allergy. and IL-13. 28 To examine whether a reduction in T H 2 immune responses is involved in suppression of diarrhea, we measured levels of OVA-induced T H 1, T H 2, and T H 17 cytokines secreted from MLN cells. T H 2 cytokines, such as IL-4, IL-5, IL-9, and IL-13, were strongly induced, whereas in contrast, the T H 1 cytokine IFN-g and the T H 17 cytokine IL-17 were not detected in the food allergy group. Interestingly, even though B longum KACC 91563 alleviated the diarrhea, T H 2 cytokine levels were not decreased (see Fig E3, A, in this article's Online Repository at www.jacionline.org). In addition, because it has been reported that some bacteria regulate food allergy through Foxp3 1 Treg cells, 29, 30 we examined whether B longum KACC 91563 and E faecalis KACC 91532 affect this cell population. Fig E3, B, shows that B longum KACC 91563 and E faecalis KACC 91532 had no influence on the proportions of Foxp3 1 Treg cells in MLNs and spleens. Moreover, although IL-10, an anti-inflammatory cytokine, is generated by Foxp3
1 Treg cells after oral antigen challenge to inhibit allergic disease, 31 production of this cytokine was not affected by B longum KACC 91563 or E faecalis KACC 91532 (see Fig E3, A) . These data imply that regulation of food allergy by B longum KACC 91563 is not mediated by increasing Foxp3 1 Treg cell counts or shifting of the T H 2 immune response to a T H 1 response.
Because mast cells are the major effector cells during the food allergy response, 22, 32 we investigated whether administration of B longum KACC 91563 reduces mast cell numbers in the intestine in a food allergy model. Mast cells in the small intestine were stained by using chloroacetate esterase activity, and it was found that B longum KACC 91563, but not E faecalis KACC 91532, strikingly reduced mast cell numbers (Fig 2, A) . Furthermore, levels of MCPT-1, which is secreted from intestinal mast cells, were markedly decreased (Fig 2, B) . However, under homeostatic conditions, mast cells were hardly detected in the small intestine, and mast cell numbers were not affected by B longum KACC 91563 without induction of food allergy (see Fig E4 in 28 Thus, we examined the level of OVA-specific IgE in the serum. However, neither B longum KACC 91563 nor E faecalis KACC 91532 had a measureable effect on the production of OVA-specific IgE (Fig 2, C) . Collectively, these data indicate that B longum KACC 91563 suppresses allergic diarrhea through selective reduction of mast cell numbers in the small intestine.
B longum KACC 91563 and its EVs specifically induce apoptosis of BMMCs B longum enhances intestinal defense and protects the host from the infection through production of short-chain fatty acids, such as acetate. 33 Therefore we hypothesized that the prevention of food allergy was caused by acetate produced by B longum KACC 91563; however, diarrhea was not attenuated by administration of acetate during the entire period or the effector phase of the food allergy model (see Fig E5 in this article' s Online Repository at www.jacionline.org).
In a recent study, Bacteroids fragilis-derived EVs were shown to contain polysaccharide A, which is known to induce Treg cells, suggesting that EVs perform similar functions to the cells from which they originate through the transport of crucial effector molecules. 34 We hypothesized that EVs of B longum KACC 91563 could induce mast cell death because only B longum KACC 91563 attenuated food allergy by decreasing mast cell numbers (Fig 2) . Thus we assessed the production of EVs released by B longum KACC 91563 and E faecalis KACC 91532. To verify the proper isolation of EVs produced by B longum KACC 91563 and E faecalis KACC 91532, we characterized the morphology and size of EVs by using the dynamic light scattering assay and TEM. EVs of B longum KACC 91563 and E faecalis KACC 91532 showed spherical morphology (Fig 3, A) and diversity of sizes with a Gaussian distribution and with the major size being 60 nm and 25 nm in diameter, respectively (Fig 3, B) . Interestingly, EVs, as well as whole bacteria, of B longum KACC 91563 increased Annexin V 1 apoptotic cells in mast cells but did not induce cell death of T cells, B cells, or eosinophils (Fig 3, C) . Apoptosis of mast cells also was confirmed by using the TUNEL assay (Fig 3, D) . EVs of B longum KACC 91563 were much more efficient in apoptosis of mast cells than whole B longum KACC 91563 bacteria (Fig 3, C and D) . However, EVs of E faecalis KACC 91532 could not induce apoptosis of mast cells significantly. These data indicate that mast cell apoptosis is selectively induced by whole bacteria and EVs of B longum KACC 91563.
EVs derived from B longum KACC 91563 and E faecalis KACC 91532 are specifically internalized by BMMCs in a temperature-insensitive manner
We hypothesized that mast cell-specific apoptosis induced by B longum KACC 91563-derived EVs might be due to only mast cells possessing the ability to take up B longum KACC 91563-derived EVs specifically. Thus, we incubated BMMCs, splenic DCs, eosinophils, T cells, and B cells with DiI-labeled EVs of B longum KACC 91563 and E faecalis KACC 91532. Specifically, BMMCs showed high uptake ability compared with other cell populations and efficiently took up EVs of E faecalis KACC 91532, as well as B longum KACC 91563 (Fig 4) , indicating that mast cells are capable of internalizing EVs of bacteria, irrespective of their origin. These results also implied that a certain component in EVs of B longum KACC 91563 is likely to be responsible for mast cell apoptosis. In fact, although DCs are well-known phagocytes, BMMCs took up the labeled EVs more readily than did DCs (Fig 4) . To exclude the possibility of phagocytosis, we incubated EVs with each type of cell under the phagocytosis-inhibiting conditions at 48C. Although the uptake ability of DCs was significantly impaired at 48C, uptake by mast cells was not markedly affected by temperature (Fig 4) . These results suggest that mast cells specifically take up EVs through an undefined receptor on their surface.
ESBP, a major protein present in B longum KACC 91563-derived EVs, attenuates food allergy symptoms
To address which component in EVs of B longum KACC 91563 participates in mast cell apoptosis, we separated proteins of EVs J ALLERGY CLIN IMMUNOL VOLUME nnn, NUMBER nn using SDS-PAGE. EVs of B longum KACC 91563 were found to be mainly comprised of 2 proteins (Fig 5, A) that were identified as ESBP and ASBP through proteomic analysis (Fig 5, A) . To perform functional studies, GST-tagged recombinant proteins of ESBP and ASBP were expressed in E coli and purified by using glutathione Sepharose beads (see Fig E6, A, in this article's Online Repository at www.jacionline.org). The purified proteins were intraperitoneally injected twice before the first and fifth OVA oral challenges to examine whether ESBP and ASBP suppress food allergy (Fig 5, B) . ESBP, but not ASBP, dramatically reduced the occurrence of diarrhea in a dose-dependent manner (Fig 5, C, and see Fig E6, B and C) . In MCPT-1 levels in serum were also decreased by recombinant ESBP protein compared with recombinant GST and ASBP protein (Fig 5, F) . These data show that ESBP specifically reduces J ALLERGY CLIN IMMUNOL VOLUME nnn, NUMBER nn the number of mast cells and alleviates diarrhea in this food allergy model.
DISCUSSION
Recently, one study suggested that reconstitution of mice with human microbiota attenuates diarrhea through induction of Treg cells. 35 Because this result indicates that human microbiota are compatible with mouse microbiota, the mouse model could be a powerful method for investigation of allergic disease and the microbiota. 36, 37 Vulnerability to allergic disease is controlled by species and degree of exposure of colonized microbiota. One way to control the composition and effects of the microbiota is to take in probiotics that assist the host in attenuating allergic disease by modulating the intestinal immune response. 38 In this report, we suggest that administration of a single strain of human probiotic bacteria, B longum KACC 91563, suppresses allergen-induced food allergy in mice.
It is critical to understand the mechanisms of action of these bacteria within the host to increase the application and clinical utility of probiotics to improve human health and prevent disease. The T H 2 immune response plays a critical role in the development FIG 5 . Suppression of food allergy responses through ESBP, a major protein of B longum KACC 91563-derived EVs. A, Proteins of B longum KACC 91563 and its EVs were analyzed by using SDS-PAGE. ESBP and ASBP were identified through proteomic analysis. B, Experimental schedule for food allergy induction and administrations of ESBP or ASBP in mice. C, Abilities of GST-tagged recombinant ESBP or ASBP (50 mg) to suppress allergic diarrhea (OVA 1 GST vs OVA 1 ESBP: ***P < .001, n 5 approximately 6-22 mice per group). Recombinant GST protein-treated mice were used as a positive control. Data are combined from 3 independent experiments. D, Paraffin-embedded sections of jejunum were stained for mast cells (original magnification 3400). E, The number of mast cells was counted in 4 different fields and represented by a bar graph (n 5 4 mice per group). Statistical analysis was performed by using 1-way ANOVA with the Newman-Keuls posttest. *P < .05. F, Levels of MCPT-1 in serum (n 5 approximately 3-6 per group). Data are representative of 2 independent experiments. i.g., Intragastric; i.p., intraperitoneal.
of allergic disorders through the release of cytokines, such as IL-4, IL-13, and IL-9. These cytokines induce mastocytosis and IgE class-switching in the intestine. 28, 39, 40 Even though depletion of T H 2 cytokines, such as IL-4 and IL-13, attenuates food allergy, 39 we could not detect the suppression of IL-4, IL-5, or IL-9 in the B longum KACC 91563-treated group. Furthermore, a recent study has reported that maintenance of oral tolerance by Foxp3 1 Treg cells is important for the prevention of food allergy. 30 Treg cells are induced by the probiotics Lactobacillus reuteri and Lactobacillus casei, which bind to dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) on DCs. 41 In addition to DCs and Treg cells, mast cells play a major role during allergic disease; however, thus far, clinical application of probiotics has focused on the modulation of T-cell polarization through DCs and not on mast cells. Here we suggest that administration of B longum KACC 91563 before food allergy induction alleviates symptoms of food allergy by reducing the number of mast cells present in the LP of the small intestine. In contrast, no evidence of an effect of this probiotic on T H 2 or Treg cells was found in these studies. If daily intake of probiotics led to suppression of steady-state T-cell activity, this could be detrimental because a successful immune response in the intestines is the first line of defense to many pathogens. However, B longum KACC 91563 is able to maintain the immune response while suppressing food allergies by affecting only mast cells, the major effector cells of this disease.
EVs are enriched for molecules, such as proteins, DNA, and lipids, inside their lipid bilayer. Compared with the soluble forms of these molecules, EVs more stably preserve and effectively transport these molecules. 42, 43 Although the component-sorting system of EVs remains to be elucidated, released EVs showed similar effects as whole bacteria. This suggests that EVs might be a supporter or even a substitute for the probiotic effects of the bacteria. Indeed, B fragilis-derived EVs alleviated colitis similarly to B fragilis and were directly internalized by DCs in vitro. 34 In light of this, it is conceivable that a component contained within B longum KACC 91563-derived EVs should exhibit suppressive effect on food allergy similarly to the whole bacteria.
The studies described herein illustrate that mast cells internalize EVs specifically (Fig 4) , although the underlying mechanism is currently unknown. Possible mechanisms sufficient to explain our results are receptor-mediated internalization and random phagocytosis. 11, 44, 45 Thus, we treated fluorescencelabeled EVs with BMMCs at 48C to exclude the possibility of random phagocytosis and confirmed that EVs are internalized by BMMCs, even under these conditions (Fig 4) . This suggests that BMMCs internalize EVs through a specific receptor-mediated pathway; however, the underlying molecular mechanism remains unclear.
Previously, many publications have suggested that probiotic-derived proteins affect the immune system in the gastrointestinal tract. For example, S layer protein A expressed on the surface of the Lactobacillus acidophilus strain NCFM binds to the DC-SIGN receptor and induces production of IL-10. Mutated L acidophilus NFCM lacking the S layer protein A induced proinflammatory cytokines in human DCs. 46 Furthermore, Lactobacillus salivarius UCC118 produces a bacteriocin in vivo that can dramatically protect mice against infection with the invasive pathogen Listeria monocytogenes.
47
In the present study, we characterized 2 proteins, ESBP and ASBP, from B longum KACC 91563-derived EVs. Of these, only ESBP had the ability to attenuate the food allergy symptoms in the mouse model. Details regarding the binding receptor for ESBP and any downstream signaling molecules affected by its binding remain to be determined. Thus, further analysis of the characteristics of ESBP, as well as the detailed molecular mechanisms underlying its anti-food allergy functions, will be required in future studies.
Because B longum KACC 91563 was isolated from neonates and targets mast cells, a major effector cell population important for the allergy response (also known as a T cell-independent immune response), use of this probiotic for treatment of food allergy is likely safe. Also, bacterial EVs are extremely small and transfer bacterial components inside their lipid bilayers to target cells in a concentrated and protected form. Thus, we propose a possible mechanism of action in which EVs of B longum KACC 91563 penetrate through intestinal epithelial cells and induce apoptosis of mast cell selectively (Fig 6) . Additionally, ESBP from B longum KACC 91563 induced a reduction in mast cell counts and alleviated food allergy symptoms in the effector phase of the food allergy model (Fig  5) . However, administration of B longum KACC 91563 only during the effector phase did not alleviate food allergy symptoms (see Fig E8 in this article' s Online Repository at www.jacionline. org), and B longum KACC 91563 seemed not to be efficient in the treatment of food allergy. Therefore, recombinant ESBP protein might be used as a drug for the treatment of food allergy, although additional investigations in food allergy models sensitized through physiologic routes, such as oral 48 and cutaneous 49 priming with adjuvant, are required. Despite numerous attempts at clinical approaches to cure allergic diseases and a growing commercial market, there are few viable treatment options. Our research suggests that proteins derived from EVs might be a novel treatment option for allergic diseases targeting mast cells. 
